Interim Report First Quarter 2024, January 1 – March 31 Kancera AB (publ.), org.no. 556806-8851
The period in brief – financial summary for the first quarter 2024 Net sales amounted to SEK 0 million (SEK 0 million) R&D expenses amounted to SEK 11,4 million (SEK 15,2 million) Operating loss for the quarter amounted to...
Read More